Sanja Pajovic

686 Bay Street
Toronto, ON M5G0A4, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Tumor-Targeted pan-RAS Inhibition as a Novel Biologic Therapy for Diffuse Midline Glioma.

Tumor-Targeted pan-RAS Inhibition as a Novel Biologic Therapy for Diffuse Midline Glioma.

Journal: Neuro-oncology

Published: January 28, 2026

The proteomic landscape of diffuse midline glioma highlights the therapeutic potential of non-histone protein methyltransferases.

The proteomic landscape of diffuse midline glioma highlights the therapeutic potential of non-histone protein methyltransferases.

Journal: Neuro-oncology

Published: February 15, 2025

Oncohistone interactome profiling uncovers contrasting oncogenic mechanisms and identifies potential therapeutic targets in high grade glioma.

Oncohistone interactome profiling uncovers contrasting oncogenic mechanisms and identifies potential therapeutic targets in high grade glioma.

Journal: Acta neuropathologica

Published: June 07, 2022

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

Journal: Molecular & cellular proteomics : MCP

Published: February 08, 2022

Splicing is an alternate oncogenic pathway activation mechanism in glioma.

Splicing is an alternate oncogenic pathway activation mechanism in glioma.

Journal: Nature communications

Published: May 27, 2021

Epigenetic activation of a RAS/MYC axis in H3.3K27M-driven cancer.

Epigenetic activation of a RAS/MYC axis in H3.3K27M-driven cancer.

Journal: Nature communications

Published: February 10, 2020

Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas.

Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas.

Journal: Cancer cell

Published: January 03, 2020

Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic glioma.

Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic glioma.

Journal: Acta neuropathologica communications

Published: July 25, 2016

ATM regulates 3-methylpurine-DNA glycosylase and promotes therapeutic resistance to alkylating agents.

ATM regulates 3-methylpurine-DNA glycosylase and promotes therapeutic resistance to alkylating agents.

Journal: Cancer discovery

Published: August 08, 2014

Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells.

Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells.

Journal: Acta neuropathologica

Published: March 07, 2014

Transcriptional and epigenetic regulation of KIF14 overexpression in ovarian cancer.

Transcriptional and epigenetic regulation of KIF14 overexpression in ovarian cancer.

Journal: PloS one

Published: June 21, 2013

Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations.

Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations.

Journal: Nature genetics

Published: April 24, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026